Lewy Body Dementia Market to Reach $1.68 Billion by 2030 at 6.9% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Lewy Body Dementia Market Expected To Scale Between 2026 And 2030?

The lewy body dementia market has shown significant expansion in recent years. It is anticipated to increase from $1.2 billion in 2025 to $1.29 billion in 2026, registering a compound annual growth rate (CAGR) of 7.2%. This historical growth can be linked to factors such as an expanding aging population, improved recognition of various dementia subtypes, increased application of neurological examinations, broader availability of hospital-based diagnoses, and a growing clinical focus on cognitive decline.

The market size for Lewy body dementia is projected to experience significant expansion in the coming years. It is anticipated to grow to $1.69 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.9%. This upward trend during the forecast period can be attributed to improved diagnostic precision, the increasing burden of chronic neurological conditions, the broadening of specialty clinic networks, an increase in caregiver and patient support initiatives, and higher healthcare spending allocated to dementia care. Furthermore, major developments expected in this period include the rising prevalence of neurodegenerative disorders, enhanced awareness and earlier identification of LBD, an increasing need for accurate differential diagnoses, the expanded use of symptom-specific medications, and a growing demand for long-term care and comprehensive disease management.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21213&type=smp

What Leading Drivers Are Supporting The Lewy Body Dementia Market Expansion?

The increasing occurrence of brain-related disorders is anticipated to stimulate the expansion of the lewy body dementia market moving forward. These disorders encompass various conditions that impact the brain’s structure and operations, resulting in issues like cognitive decline, memory impairment, and changes in behavior. Their prevalence is on the rise due to elements such as aging populations, genetic predispositions, and environmental factors. This growing prevalence of brain-related disorders heightens the need for improved treatments and earlier diagnosis for lewy body dementia, consequently fostering research, investment, and innovation, which facilitates quicker progress in LBD diagnosis and therapy. As an illustration, in October 2023, the World Federation of Neurology, a UK-based association of national neurological societies, reported that over 40% of the worldwide population experiences neurological conditions, a burden projected to nearly double by 2050. Thus, the escalating prevalence of brain-related disorders will fuel the growth of the lewy body dementia market.

What Are The Key Segment Divisions In The Lewy Body Dementia Market Segment Structure?

The lewy body dementia market covered in this report is segmented –

1) By Diagnosis: Clinical Diagnosis, Biomarker-Based Diagnosis

2) By Medication: Cholinesterase Inhibitors, Antipsychotics, Antidepressants, Other Medications

3) By End-User: Hospitals, Specialty Clinics, Long-Term Care Facilities, Other End-Users

Subsegments:

1) By Clinical Diagnosis: Neuropsychological Testing, Neurological Examination, Medical History Review, Cognitive Function Assessment

2) By Biomarker-Based Diagnosis: Cerebrospinal Fluid (CSF) Biomarkers, Imaging Biomarkers (PET, MRI)

What Emerging Trends Are Seen In The Lewy Body Dementia Market?

Major companies operating within the lewy body dementia market are prioritizing research investment to create more effective neurodegenerative treatments. This commitment to research involves dedicating financial resources, time, and effort to scientific and technological studies with the goal of uncovering new insights, developing innovative solutions, or enhancing current practices. Such investment supports the exploration of diseases and the formulation of new medications, all ultimately aiming to improve patient outcomes. For instance, in March 2023, the National Institute on Aging, a US-based government agency, awarded $21 million to aid drug development research for Lewy Body Dementia (LBD). Researchers at the University of Miami Miller School of Medicine are initiating a Phase 2b study of neflamapimod, following promising early results.

Which Organizations Are Engaged In The Lewy Body Dementia Market?

Major companies operating in the lewy body dementia market are Eli Lilly and Company, Mayo Foundation for Medical Education and Research, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Georgetown University Medical Center, Alzheimer’s Society, BioArctic AB, Annovis Bio Inc., Sun Pharma Advanced Research Company Limited, Voyager Therapeutics Inc., Cognition Therapeutics, Athira Pharma, Allergan plc, Inhibikase Therapeutics, CuraSen Therapeutics Inc., CervoMed Inc., AC Immune SA, ProMIS Neurosciences Inc., Aptinyx Inc., EIP Pharma Inc.

Get The Full Lewy Body Dementia Market Report:

https://www.thebusinessresearchcompany.com/report/lewy-body-dementia-global-market-report

Where Is The Lewy Body Dementia Market Primarily Concentrated By Region?

North America was the largest region in the lewy body dementia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lewy body dementia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Lewy Body Dementia Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/lewy-body-dementia-global-market-report

Browse Through More Reports Similar to the Global Lewy Body Dementia Market 2026, By The Business Research Company

Alzheimers Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report

Alzheimers Drugs Market Report

https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report

Elderly Care Market Report

https://www.thebusinessresearchcompany.com/report/elderly-care-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795